Kintor Soars On COVID Antiviral Data But Results' Significance Still Unclear

 
• By Dexter Jie Yan
  
China oral antiviral
proxalutamide among China's first oral antiviral candidates for COVID-19 • Source: Alamy

More from China

More from Focus On Asia